Reuters logo
BRIEF-Amicus Therapeutics announces additional positive data in Pompe disease phase 1/2 study at World Muscle Society
October 4, 2017 / 10:07 AM / 15 days ago

BRIEF-Amicus Therapeutics announces additional positive data in Pompe disease phase 1/2 study at World Muscle Society

Oct 4 (Reuters) - Amicus Therapeutics Inc:

* Amicus Therapeutics announces additional positive data in Pompe disease phase 1/2 study at World Muscle Society

* Amicus Therapeutics Inc - ‍pulmonary function generally improved or remained stable at 6 and 9 months​

* Amicus Therapeutics - plans to continue collaborative discussions with regulators in US and EU, expects to provide update in first half of 2018 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below